GAMMA HYDROXYBUTYRATE IN MONKEY .4. DOPAMINERGIC MECHANISMS

[1] EFFECTS OF DRUGS INFLUENCING MONOAMINE MECHANISMS ON INCREASE IN BRAIN DOPAMINE PRODUCED BY AXOTOMY OR TREATMENT WITH GAMMAHYDROXYBUTYRIC ACID [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1973, 278 (04) : 363 - 372

[2] BESSON MJ, 1971, J PHARMACOL EXP THER, V177, P196

[3] CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140

[4] BIOCHEMICAL AND HISTOCHEMICAL STUDIES ON EFFECTS OF IMIPRAMINE-LIKE DRUGS AND (+)-AMPHETAMINE ON CENTRAL AND PERIPHERAL CATECHOLAMINE NEURONS [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1966, 67 (3-4): : 481 - +

[5] Consolo S, 1975, Adv Neurol, V9, P257

[6] DRAKONTIDES AB, 1962, J PHARMACOL EXP THER, V135, P275

[7] EEG-SYNCHRONIZING EFFECT OF GAMMA-HYDROXYBUTYRATE AND 1-HYDROXY-3-AMINO-PYRROLIDONE-2 (HA-966) IN RELATION TO DOPAMINERGIC BRAIN-FUNCTION [J]. NEUROPHARMACOLOGY, 1975, 14 (08) : 591 - 599

[8] GESSA G. L., 1966, LIFE SCI, V5, P1921, DOI 10.1016/0024-3205(66)90261-X

[9] SELECTIVE INCREASE OF BRAIN DOPAMINE INDUCED BY GAMMA-HYDROXYBUTYRATE - STUDY OF MECHANISM OF ACTION [J]. JOURNAL OF NEUROCHEMISTRY, 1968, 15 (05) : 377 - &

[10] SOME NEUROCHEMICAL ASPECTS OF DEPRESSANT ACTION OF GAMMA-BUTYROLACTONE ON CENTRAL NERVOUS SYSTEM [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1963, 20 (03): : 563 - &

[1] EFFECTS OF DRUGS INFLUENCING MONOAMINE MECHANISMS ON INCREASE IN BRAIN DOPAMINE PRODUCED BY AXOTOMY OR TREATMENT WITH GAMMAHYDROXYBUTYRIC ACID [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1973, 278 (04) : 363 - 372

[2] BESSON MJ, 1971, J PHARMACOL EXP THER, V177, P196

[3] CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140

[4] BIOCHEMICAL AND HISTOCHEMICAL STUDIES ON EFFECTS OF IMIPRAMINE-LIKE DRUGS AND (+)-AMPHETAMINE ON CENTRAL AND PERIPHERAL CATECHOLAMINE NEURONS [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1966, 67 (3-4): : 481 - +

[5] Consolo S, 1975, Adv Neurol, V9, P257

[6] DRAKONTIDES AB, 1962, J PHARMACOL EXP THER, V135, P275

[7] EEG-SYNCHRONIZING EFFECT OF GAMMA-HYDROXYBUTYRATE AND 1-HYDROXY-3-AMINO-PYRROLIDONE-2 (HA-966) IN RELATION TO DOPAMINERGIC BRAIN-FUNCTION [J]. NEUROPHARMACOLOGY, 1975, 14 (08) : 591 - 599

[8] GESSA G. L., 1966, LIFE SCI, V5, P1921, DOI 10.1016/0024-3205(66)90261-X

[9] SELECTIVE INCREASE OF BRAIN DOPAMINE INDUCED BY GAMMA-HYDROXYBUTYRATE - STUDY OF MECHANISM OF ACTION [J]. JOURNAL OF NEUROCHEMISTRY, 1968, 15 (05) : 377 - &

[10] SOME NEUROCHEMICAL ASPECTS OF DEPRESSANT ACTION OF GAMMA-BUTYROLACTONE ON CENTRAL NERVOUS SYSTEM [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1963, 20 (03): : 563 - &